Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joerg Herrmann

Showing results (261-270 of 269) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 269 results.
Circulation. Cardiovascular Quality and Outcomes|September 13, 2023
Global Cardio Oncology Registry (G-COR): Registry Design, Primary Objectives, and Future Perspectives of a Multicenter Global InitiativeArco J Teske, Rohit Moudgil, Teresa López-Fernández, et al.
Circulation Research|June 2, 2023
An ERK5-NRF2 Axis Mediates Senescence-Associated Stemness and AtherosclerosisJun-Ichi Abe, Masaki Imanishi, Shengyu Li, et al.
Redox Biology|October 7, 2021
Nucleus-mitochondria positive feedback loop formed by ERK5 S496 phosphorylation-mediated poly (ADP-ribose) polymerase activation provokes persistent pro-inflammatory senescent phenotype and accelerates coronary atherosclerosis after chemo-radiationSivareddy Kotla, Aijun Zhang, Masaki Imanishi, et al.
Frontiers in Cardiovascular Medicine|October 2, 2023
Premature senescence and cardiovascular disease following cancer treatments: mechanistic insightsAshita Jain, Diego Casanova, Alejandra Valdivia Padilla, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 16, 2025
Reevaluating Anti-Inflammatory Therapy: Targeting Senescence to Balance Anti-Cancer Efficacy and Vascular DiseaseBernardo Casso-Chapa, Norma Alicia Vazquez González, Nhat-Tu Le, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Downregulation of LATS1/2 Drives Endothelial Senescence-Associated Stemness (SAS) and Atherothrombotic Lesion FormationSivareddy Kotla, Jonghae Lee, Kyung Ae Ko, et al.
Circulation Research|May 27, 2026
LATS1/2-CD38 Metabolic Rewiring Links Senescence to Intraplaque ThrombosisSivareddy Kotla, Jonghae Lee, Kyung Ae Ko, et al.
European Journal of Heart Failure|August 1, 2024
Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-OncologyCarlo Gabriele Tocchetti, Dimitrios Farmakis, Yvonne Koop, et al.
European Journal of Heart Failure|May 29, 2020
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology SocietyAlexander R Lyon, Susan Dent, Susannah Stanway, et al.
Pageof 27

Showing results (261-270 of 269) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 269 results.
Circulation. Cardiovascular Quality and Outcomes|September 13, 2023
Global Cardio Oncology Registry (G-COR): Registry Design, Primary Objectives, and Future Perspectives of a Multicenter Global InitiativeArco J Teske, Rohit Moudgil, Teresa López-Fernández, et al.
Circulation Research|June 2, 2023
An ERK5-NRF2 Axis Mediates Senescence-Associated Stemness and AtherosclerosisJun-Ichi Abe, Masaki Imanishi, Shengyu Li, et al.
Redox Biology|October 7, 2021
Nucleus-mitochondria positive feedback loop formed by ERK5 S496 phosphorylation-mediated poly (ADP-ribose) polymerase activation provokes persistent pro-inflammatory senescent phenotype and accelerates coronary atherosclerosis after chemo-radiationSivareddy Kotla, Aijun Zhang, Masaki Imanishi, et al.
Frontiers in Cardiovascular Medicine|October 2, 2023
Premature senescence and cardiovascular disease following cancer treatments: mechanistic insightsAshita Jain, Diego Casanova, Alejandra Valdivia Padilla, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 16, 2025
Reevaluating Anti-Inflammatory Therapy: Targeting Senescence to Balance Anti-Cancer Efficacy and Vascular DiseaseBernardo Casso-Chapa, Norma Alicia Vazquez González, Nhat-Tu Le, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Downregulation of LATS1/2 Drives Endothelial Senescence-Associated Stemness (SAS) and Atherothrombotic Lesion FormationSivareddy Kotla, Jonghae Lee, Kyung Ae Ko, et al.
Circulation Research|May 27, 2026
LATS1/2-CD38 Metabolic Rewiring Links Senescence to Intraplaque ThrombosisSivareddy Kotla, Jonghae Lee, Kyung Ae Ko, et al.
European Journal of Heart Failure|August 1, 2024
Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-OncologyCarlo Gabriele Tocchetti, Dimitrios Farmakis, Yvonne Koop, et al.
European Journal of Heart Failure|May 29, 2020
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology SocietyAlexander R Lyon, Susan Dent, Susannah Stanway, et al.
Pageof 27